The use of diabetes drugs reduced the risk of AKI by 8% (OR = 0.92, p = 0.01) in the HDL group, although it was not statistically significant for the apoA1 group (OR = 1.00, p = 0.33). Here, APOA1 is linked to diabetes mellitus.